CADTH has introduced a new type of recommendation. Time-limited drug reimbursement recommendations are a new recommendation category that will aim to ...
Latest News
September 28, 2023
CADTH is pleased to announce the election of 3 new members to the CADTH Board of Directors.
“On behalf of the Board, I am pleased to welcome Louise ...
August 30, 2023
The international collaboration between 6 health technology assessment (HTA) bodies from across the UK, Australia, and Canada welcomes 2 further HTA ...
August 24, 2023
CADTH is establishing an industry task force that will build upon the recently released Guidance for Reporting Real-World Evidence to provide advice ...
August 18, 2023
A message from Suzanne McGurn, President and CEO, CADTH
On behalf of CADTH and our Board of Directors, I’m pleased to share the CADTH Annual Report for ...
August 3, 2023
As CADTH continues along the path of strategic transformation, we’re working hard to align the evidence products we deliver with the priority needs of ...
July 20, 2023
Upcoming Events
All Upcoming Events22nd Annual Market Access Summit
Event Date: October 11 to 12, 2023 Event Location: Toronto, Ontario CADTH’s Amanda Allard, Director of Pharmaceutical Reviews, and Patricia Caetano ...
CADTH Webinar – Equity in Evidence
Event Date: Thursday, October 19, 2023, 1:00 p.m. to 2:00 p.m. ET Free Online Event. Join us for a special webinar to mark World Evidence-Based ...
National Town Hall on Real-World Evidence: Update on Ongoing Canadian Initiatives
Event Date: Sunday, October 22, 2023, from 1:00 p.m. to 4:30 p.m. ET Event Location: Toronto, Ontario The Canadian Association for Population ...